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TOTAL IgE DETECTION IN PAIRED CEREBROSPINAL FLUID AND SERUM SAMPLES FROM
PATIENTS WITH NEUROCYSTICERCOSIS(1)
Ednéia Casagranda BUENO(2, 3), Adelaide José VAZ(3), Luís dos Ramos MACHADO(4) & José Antônio LIVRAMENTO(4)
SUMMARY
Neurocysticercosis (NC), the presence of Taenia solium metacestodes in tissues, is the most frequent and severe parasitic infection
of the central nervous system. We investigated the presence of total IgE by an automated chemiluminescence assay in 53 paired
cerebrospinal fluid (CSF) and serum samples from patients with NC (P) and in 40 CSF samples from individuals with other neurological
disorders as the control group (C). Total IgE concentration ranged from 1.2 to 6.6 IU/ml (mean = 1.4 IU/ml, standard deviation-sd =
1.1 IU/ml) in 28.3% of CSF samples from the P group, a value significantly higher than for the C group (≤1.0 IU/ml). The serum
samples from the P group showed concentrations ranging from 1.0 to 2330.0 IU/ml (mean = 224.1 IU/ml, sd = 452.1 IU/ml), which
were higher than the normal value cited by the manufacturer (<100.0 IU/ml) in 32.1% of the samples. A significant difference was
observed in CSF samples from the P and C groups (p = 0.005) and in serum samples from the P group compared to the normal value
(p = 0.005), with sera showing more frequent abnormal results.
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INTRODUCTION
Neurocysticercosis (NC), the presence of Taenia solium metacestodes
in tissues, is the most frequent and severe parasitic infection of the central
nervous system. Its distribution is universal, being frequent in developing
countries in Latin America, Africa, Asia and India1,9,16,18,20, and with cases
reported in the United States due to the immigration of individuals coming
from endemic areas17.
The diagnosis of NC is based on clinical, epidemic and laboratory
data (neuroimaging and immunological methods). Since clinical
diagnosis is hindered by the nonspecific and polymorphic
symptomatology of NC, the detection of anti-T. solium antibodies in
cerebrospinal fluid (CSF) represents an important diagnostic
factor2,8,9,13,22,23.
Most of the antibodies found in CSF are intrathecally synthesized,
with a smaller proportion coming from peripheral blood by blood-brain
barrier rupture7. Some authors have reported specific IgG, IgM, IgA and
IgE antibodies in CSF and/or serum from patients with NC, without a
correlation between antibody class and clinical aspect of the disease3,5,6,12.
In parasitic infections, including the teniasis-cysticercosis complex, the
level of total IgE can be high, many times without the identification of
the specificity of the antibody14,19.
The objective of the present study was to investigate the total IgE
antibodies in CSF and serum samples from patients with NC by a
chemiluminescence assay.
MATERIAL AND METHODS
We studied 53 paired CSF and serum samples from patients with
NC (P) selected according to the General Protocol of NC Investigation
followed at the Center of Neurological Investigations, University
Hospital, Faculty of Medicine of the University of São Paulo. The study
was approved by the Ethics Committee for Analysis of Research Projects,
Clinical Management of UHFMUSP, 072/97, in agreement with
Resolution 196/96 of the National Council of Health, Ministry of Health,
Brasilia, Brazil. The patients’ age ranged from 15 to 72 years [mean, 40
years; standard deviation (sd), 13 years].
As a control group (C) we studied 40 CSF samples from individuals
with other non-NC neurological disorders in order to evaluate the method
of CSF sample analysis. For serum samples we considered the normal
value to be 100.0 IU/ml, as cited by the manufacturer.
We detected total IgE using an automated chemiluminescence assay
(IMMULITE Total IgE, DPC Diagnostic Products Corporation, Los
Angeles, USA).
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In the test, an antibody sandwich complex is formed between IgE of
sample, solid-phase (polystirene bead coated with a polyclonal antibody
specific for IgE) and conjugate (alkaline phosphatase-conjugated IgE
monoclonal antibody). Unbound enzyme conjugated is removed by a
centrifugal wash, after which chemiluminescent substrate (phosphate
ester of adamantyl dioxetane) is added. The chemiluminescent substrate
undergoes hydrolysis in the presence alkaline phosphatase to yield an
unstable intermediate, that results in the sustained emission of light. The
bound complex (photon output) as measured by the luminometer, and is
proportional to the concentration of total IgE in the sample, calculated
starting from standard curve.
The mean and standard deviations were calculated for each group
and the data analyzed by the Mann-Whitney test (Software INSTAT).
RESULTS
Total IgE, reported as IU/ml, for the CSF and serum samples analyzed
by chemiluminescence are presented in Figure 1.
In 28.3% of CSF samples from the P group, total IgE concentration
ranged from 1.2 to 6.6 IU/ml [mean, 1.4 IU/ml; sd, 1.1 IU/ml], values
significantly higher than those detected in the C group (p = 0.005). The
40 CSF samples from the C group showed IgE levels lower 1.0 IU/ml
(Figure 1).
In 32.1% of serum samples from the P group, total IgE concentrations
were higher than normal (up to 100.0 IU/ml). The concentrations obtained
for all serum samples ranged from 1.0 to 2330.0 IU/ml (mean, 224.1 IU/
ml; sd, 452.1 IU/ml) (Figure 1).
The results showed 15.1% of paired CSF and serum samples with
total IgE concentration higher than normal values and/or controls. CSF
IgE levels differed significantly between the P and C groups (p = 0.005),
and serum IgE levels differed significantly between the P group and
normal values (p = 0.005).
DISCUSSION
The biological parasite-host interactions involved in NC are complex
because of the different evolutionary stages of the parasite and of the
individual variations in the response of the host17. The mechanisms of the
humoral immune response have been studied especially during the active
phase of the disease, and several authors have detected IgG antibodies in
CSF and/or serum from patients with NC3,6,7,8. There are only few reports
about the immune response in different evolutionary stages of NC4.
Fig. 1 - Total IgE levels (IU/ml) determined by chemiluminescence in 53 CSF and serum samples from patients with neurocysticercosis and in 40 CSF samples
IU
/m
l
Patients Controls Patients  
0
2
4
6
8
10
510
1010
1500
2000
2500
CSF Sera
Reference
Value
(100 IU/ml)
Detection
Limit
(1 IU/ml)
BUENO, E.C.; VAZ, A.J.; MACHADO, L. dos R. & LIVRAMENTO, J.A. - Total IgE detection in paired cerebrospinal fluid and serum samples from patients with neurocysticercosis. Rev.
Inst. Med. trop. S. Paulo, 42(2): 67-70, 2000.
69
The level of total IgE has been determined by different methods in
parasitic infections, including NC10,14,19,21. OSTROSKY-ZEICHNER et
al.15, reported that total IgE levels determined by radioimmunoassay
were higher than control in 59% of CSF samples from patients with NC.
In contrast to these findings, we observed only 28.3% CSF samples
from the P group with higher total IgE concentration than in the C group.
We observed a mean total IgE concentration of 1.4 IU/ml in CSF samples
from the P group, similar to the values reported by SPINA-FRANÇA et
al.21 and OSTROSKY-ZEICHNER et al.15, but different from those
reported by GOLDBERG et al.10 (0.44 IU/ml), and MELO et al.14 (0.76
IU/ml). The first three groups used radioimmunoassay, and the last one
used an immunoenzymatic test with a fluorigenic substrate.
The serum samples showed 224.1 IU/ml of total IgE, similar to
GORODEZKY et al.11. These authors detected higher IgE concentrations
in 52% of the serum samples from patients with NC than in the control
group, as opposed to a 32.1% rate in the present study. Some authors10
have reported higher mean concentrations of total IgE (516.0 IU/ml) in
serum samples from patients with NC than we observed here, while
others19 reported a lower concentration (28.6 IU/ml) detected by
radioimmunoassay.
Although only 2 (3.8%) CSF samples and 7 (13.2%) serum samples
showed specific IgE by ELISA (data not shown), the results indicate
that the humoral immune response in NC also involves total IgE
production. The present results confirm the complex parasite-host
relationship involved in NC, whose full elucidation requires further
investigation.
RESUMO
Detecção de IgE total em amostras pareadas de líquido
cefalorraquiano e soro de pacientes com neurocisticercose
Neurocisticercose (NC), causada pela presença da forma larvária de
Taenia solium em tecidos, é a mais frequente e grave infecção parasitária
que acomete o sistema nervoso central. Nós investigamos a presença de
IgE total por quimiluminescência em 53 amostras pareadas de líquido
cefalorraquiano (LCR) e soro de pacientes com NC (P) e 40 amostras de
LCR de indivíduos portadores de outras desordens neurológicas como
grupo controle (C). A detecção de IgE total mostrou 28,3% das amostras
de LCR do grupo P com concentrações entre 1,2 UI/ml e 6,6 UI/ml
(média = 1,4 UI/ml, desvio padrão-sd = 1,1 UI/ml), maiores que o grupo
C (≤1,0 UI/ml). As amostras de soro do grupo P mostraram concentrações
entre 1,0 UI/ml e 2330,0 UI/ml (média = 224.1 UI/ml, sd = 452,1 UI/
ml), e 32,1% das amostras apresentaram valores maiores que o valor
normal citado pelo fabricante (<100,0 UI/ml). Diferença significativa
foi encontrada entre as amostras de LCR dos grupos P e C (p = 0,005) e
entre as amostras de soro do grupo P e valor de referência (p = 0,005),
sendo os resultados dos soros mais frequentemente alterados.
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